StockData
CTTHOTCPharmaceutical PreparationsFiscal year ends December 31

CTT PHARMACEUTICAL HOLDINGS, INC.

Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Sep 17, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026

Market cap
$1.26M
P/E (TTM)
–
Dividend yield
–

CTT PHARMACEUTICAL HOLDINGS, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Ctt Pharmaceutical does not break out revenue by segment, region or product in the tagged data of its filings for this period type.